EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Prostate cancer and liquid biopsies: Clinical applications and challenges

Fumihiko Urabe iD, Takayuki Sumiyoshi iD, Kojiro Tashiro, Takayuki Goto iD, Takahiro Kimura iD, Takashi Kobayashi iD

International Journal of Urology · 2024

DOI: 10.1111/iju.15441 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Urology, 2024. Verfasst von Fumihiko Urabe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Jikei University School of Medicine, Minato City, Tokyo, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Extracellular Vesicles, Biomarkers, Tumor. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 102 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liquid biopsy has emerged as a valuable and minimally invasive tool for real‐time detection of clinically actionable abnormalities across various cancer types. Its applicability is particularly compelling in the realm of prostate cancer, where novel therapeutic agents, including those targeting DNA repair systems, are under development. Despite these advancements, challenges persist in effectively screening for prostate cancer, enhancing risk stratification, and determining optimal approaches for treating advanced disease. Consequently, there is a pressing need for improved biomarkers to aid clinicians in decision‐making within these contexts. Cell‐free DNA and extracellular vesicle analysis have demonstrated promise in diagnosis, prognostication, assessment of treatment responses, and identification of emerging mechanisms of resistance. Nevertheless, obstacles must be addressed before liquid biopsies can be integrated into routine clinical practice. These challenges encompass preanalytical considerations such as sample collection and storage, methods of extracellular vesicle isolation and enrichment, and the need for enhanced interpretation of generated sequencing data. This review provides a comprehensive overview of current clinical opportunities in managing prostate cancer through blood‐based liquid biopsy, highlighting the progress made, and acknowledging the challenges that remain. Additionally, we discuss the next steps required for the effective implementation of liquid biopsies in guiding personalized treatment strategies for prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsExtracellular VesiclesBiomarkers, TumorHumansLiquid BiopsyMalePrecision MedicinePrognosisCell-Free Nucleic AcidsEarly Detection of CancerProstate

Stichwörter der Autor:innen

circulating DNAextracellular vesiclesliquid biopsyprostate cancer

Substanzen

Biomarkers, TumorCell-Free Nucleic Acids

Autor:innen und Institutionen

  • Department of Urology, The Jikei University School of Medicine, Minato City, Tokyo, Japan.
  • Department of Urology, Kyoto University School of Medicine, Kyoto, Japan.

ORCID-Profile: Fumihiko Urabe, Takayuki Sumiyoshi, Takayuki Goto, Takahiro Kimura, Takashi Kobayashi

Zitieren

APA

Urabe, F., Sumiyoshi, T., Tashiro, K., Goto, T., Kimura, T., & Kobayashi, T. (2024). Prostate cancer and liquid biopsies: Clinical applications and challenges. International Journal of Urology. https://doi.org/10.1111/iju.15441

Vancouver

Urabe F, Sumiyoshi T, Tashiro K, Goto T, Kimura T, Kobayashi T. Prostate cancer and liquid biopsies: Clinical applications and challenges. International Journal of Urology. 2024. doi:10.1111/iju.15441

BibTeX
@article{Urabe2024,
  author = {Urabe, Fumihiko and Sumiyoshi, Takayuki and Tashiro, Kojiro and Goto, Takayuki and Kimura, Takahiro and Kobayashi, Takashi},
  title = {Prostate cancer and liquid biopsies: Clinical applications and challenges},
  journal = {International Journal of Urology},
  year = {2024},
  doi = {10.1111/iju.15441}
}
Kostenlos starten →